Virtual Nurse and Social Worker Palliative Care for Veterans with Heart Failure or COPD
This study is testing if a virtual team of a nurse and social worker can improve the quality of life for Veterans with heart failure (a condition where the heart can't pump enough blood) or chronic obstructive pulmonary disease (COPD, a group of lung diseases that block airflow and make it hard to breathe). Many Veterans with these conditions experience symptoms like breathlessness, fatigue, depression, and anxiety. The virtual team will provide direct care by phone or video, with the nurse helping manage symptoms and the social worker offering counseling. The study aims to see if this approach improves overall quality of life, depression, and anxiety. You might be able to join if you are a Veteran aged 18 or older, have had a primary care visit in the last year, and have been diagnosed with heart failure, COPD, or interstitial lung disease (a group of lung diseases that cause scarring of lung tissue). The study is currently recruiting 420 participants.
- Study design
- This is an interventional study with a planned enrollment of 420 participants. It compares a virtual nurse and social worker palliative care team with enhanced or standard implementation support.
- What's involved
- Your quality of life will be assessed every 6 months from before the study starts through a sustainment period of up to approximately 30 months. The main comparison of effectiveness will be at the end of your intervention period, which is about 4-6 months after you join.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your health-related quality of life will be assessed every 6 months from pre-implementation through sustainment, which can be up to approximately 30 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD
At a glance
Conditions
NCT07714252
Where you'd take part
This study runs at 7 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Cheyenne VA Medical, Cheyenne, WY
Cheyenne, Wyomingno site contact published
Lebanon VA Medical Center, Lebanon, PA
Lebanon, Pennsylvaniano site contact published
Overton Brooks VA Medical Center, Shreveport, LA
Shreveport, Louisianano site contact published
Phoenix VA Health Care System, Phoenix, AZ
Phoenix, Arizonano site contact published
Providence VA Medical Center, Providence, RI
Providence, Rhode Islandno site contact published
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Coloradono site contact published
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, Californiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- David Bekelman, MD MPH · PRINCIPAL_INVESTIGATOR · Rocky Mountain Regional VA Medical Center, Aurora, CO
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Health-Related Quality of Life - Functional Assessment of Chronic Illness Therapy-General (FACT-G) Total ScoreAssessed every 6 months from pre-implementation through sustainment (up to approximately 30 months); primary effectiveness comparison at the end of each Veteran's intervention period (approximately 4-6 months after enrollment)
The FACT-G is a 27-item Veteran-reported measure of health-related quality of life across four domains: physical, social/family, emotional, and functional well-being. Total scores range from 0 to 108, with higher scores indicating better quality of life. A 4-point difference represents the minimal clinically important difference in this population.